Covaxin gets emergency use approval from DCGI for children above 12 years

Covaxin gets emergency use approval from DCGI for children above 12 years Bharat Biotech informed that Covaxin is documented with excellent safety and immunogenicity data readouts in children https://ift.tt/eA8V8J